메뉴 건너뛰기




Volumn 2, Issue 1, 2007, Pages 91-92

Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: A case report

Author keywords

Bronchioalveolar carcinoma; Chemotherapy; Gefitinib

Indexed keywords

CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; ETOPOSIDE; GEFITINIB; NAVELBINE; VINCA ALKALOID; VINFLUNINE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

EID: 34249665069     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/s1556-0864(15)30026-5     Document Type: Article
Times cited : (5)

References (3)
  • 1
    • 2442661845 scopus 로고    scopus 로고
    • Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy
    • Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004;22:1589-1597.
    • (2004) J Clin Oncol , vol.22 , pp. 1589-1597
    • Hanna, N.1    Shepherd, F.A.2    Fossella, F.V.3
  • 3
    • 25844481618 scopus 로고    scopus 로고
    • Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy
    • Bianco R, Troiani T, Tortora G, Ciardello F. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy. Endocr Relat Cancer 2005;12:S159-S171.
    • (2005) Endocr Relat Cancer , vol.12
    • Bianco, R.1    Troiani, T.2    Tortora, G.3    Ciardello, F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.